| Darcy Ann Humphrey, RN | |
|
1115 B Street, Plummer, ID 83851 | |
| (208) 686-1931 | |
| Not Available |
| Full Name | Darcy Ann Humphrey |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Ambulatory Care |
| Location | 1115 B Street, Plummer, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528058427 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP2201X | Registered Nurse - Ambulatory Care | N24960 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darcy Ann Humphrey, RN Po Box 388, Plummer, ID 83851-0388 Ph: (208) 686-1931 | Darcy Ann Humphrey, RN 1115 B Street, Plummer, ID 83851 Ph: (208) 686-1931 |
News Archive
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, has reached another important milestone in the official marketing authorisation process for its lead product Glybera(R), AMT's proprietary product for lipoprotein lipase deficiency (LPLD).
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Scientists have puzzled over just why organisms evolved aging as a strategy, and now there appears to be an answer. Allowing one individual to carry all the cellular damage inflicted over time, rather than dividing it between two organisms during reproduction, increases the chances that the individual's line will continue to reproduce for many generations to come, a new study indicates.
Amsel Medical Corporation today announced that it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Amsel Occluder Device.
Researchers at Children's Hospital of Philadelphia (CHOP) have developed a proof-of-concept treatment for blood disorders like sickle cell disease and beta-thalassemia that could raise hemoglobin levels by activating production of both fetal and adult hemoglobin.
› Verified 9 days ago
Mrs. Ada M Denny, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1115 B St, Benewah Medical Center, Plummer, ID 83851 Phone: 208-686-1931 Fax: 208-686-1035 | |
Mrs. Kacie Marie Peacock, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4440 Highway 5, Plummer, ID 83851 Phone: 559-859-3168 | |
Mrs. Ginger Caroline Carpenter, RN MSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1115 B St, Plummer, ID 83851 Phone: 208-686-1931 Fax: 208-686-0242 | |
Ms. Cathy A Armstrong, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 A St, Plummer, ID 83851 Phone: 208-686-1767 | |
Mrs. Susan Mary Bates, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1115 B Street, Plummer, ID 83851 Phone: 208-686-1931 Fax: 208-686-1035 | |
Mrs. Tamara S Hise, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 A St, Plummer, ID 83851 Phone: 208-686-1931 Fax: 208-686-8052 |